Nifedipine Tablet, Extended Release
Product Images NDC 68682-105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 68682-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-30mg.jpg (Label 30mg)

Label-30mg.jpg (Label 30mg)
Label for NIFEdipine Extended-Release Tablets, USP 30 mg by Oceanside Pharmaceuticals. The packaging indicates an oral tablet dosage form, with 300 tablets in the package. The label includes storage instructions to keep the product between 15° to 30°C and protect it from light and moisture. The label also includes a barcode and mentions the product is Rx only.*
FDA Label Image

Nifedipine Chemical Structure (Nifedipine 01)

Nifedipine Chemical Structure (Nifedipine 01)
Chemical structure diagram of nifedipine showing its molecular arrangement with functional groups including methyl, nitro, and acetyl moieties attached to a heterocyclic ring with a benzene substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.